Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | CCR3 | P51677 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1809974 | 1.00 | HPGD (0.47) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1811191 | 0.96 | HPGD (0.48) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1811189 | 0.96 | HPGD (0.48) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1807385 | 0.94 | HPGD (0.45) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1807387 | 0.94 | HPGD (0.45) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1813489 | 0.94 | HPGD (0.46) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1813488 | 0.94 | HPGD (0.46) | HPGDCCR3ALDH1A1NPSR1ALOX15 | |
| SCHEMBL1807606 | 0.94 | HPGD (0.49) | HPGDALDH1A1NPSR1ALOX15POLB | |
| SCHEMBL1807608 | 0.94 | HPGD (0.49) | HPGDALDH1A1NPSR1ALOX15POLB | |
| SCHEMBL1806553 | 0.93 | HPGD (0.47) | HPGDALDH1A1NPSR1ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2042499-B1 | SALT OF A MORPHOLINE COMPOUND | MITSUBISHI TANABE PHARMA CORP (JP) | 2018-06-27 | — | — | EP | disclosed |
| EP-1801108-B9 | MORPHOLINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATIONS | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-11-20 | — | — | EP | disclosed |
| EP-1801108-B1 | MORPHOLINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATIONS | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-11-14 | — | — | EP | disclosed |
| US-8030303-B2 | Salt of morpholine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-10-04 | — | — | US | disclosed |
| US-7935700-B2 | Morpholine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20090264430-A1 | Salt of morpholine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-2042499-A1 | SALT OF MORPHOLINE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20070265257-A1 | Morpholine Compound | MITSUBISHI PHARMA CORPORATION (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1801108-A1 | MORPHOLINE COMPOUND | Mitsubishi Pharma Corporation (JP) | 2007-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264430-A1 | Salt of morpholine compound | SLC11A2, SLC16A7, AVPR2 | HPGD 2722/4885CCR3 4068/4885ALDH1A1 996/4885 |
| US-20070265257-A1 | Morpholine Compound | CCR3, CCR1, CCR4 | HPGD 3730/4885CCR3 1/4885ALDH1A1 2661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.